Eye-Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis.

Saved in:
Bibliographic Details
Title: Eye-Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis.
Authors: Essayagh S; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Aridi T; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Turunen T; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Choi L; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Adam H; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Patel N; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Scali ST; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Fisher MD; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Skaf K; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Csizmadia E; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Brennan P; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Sadek A; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Skaf J; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Zhan M; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Hansen E; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Shamloo M; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., DeStefino NR; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Clermont AC; The Eye Unit, Joslin Diabetes Center, Boston, Massachusetts, USA., Angolano C; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Ferran C; Department of Surgery, The Division of Vascular and Endovascular Surgery and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; The Transplant Institute and the Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2025 Nov 30; Vol. 39 (22), pp. e71226.
Publication Type: Journal Article
Journal Info: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-6860
DOI:10.1096/fj.202500419R